These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 472263)

  • 1. Radiation exposure to medical personnel during iodine-125 seed implantation of the prostate.
    Liu J; Edwards FM
    Radiology; 1979 Sep; 132(3):748-9. PubMed ID: 472263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose to fingertips of staff preparing stranded iodine-125 seeds for permanent prostate implants.
    van Haaren PM; van't Riet A; Moerland MA; Koedooder C; Westendorp H
    Radiat Prot Dosimetry; 2011 Apr; 145(1):61-5. PubMed ID: 21112885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation exposure after permanent prostate brachytherapy.
    Cattani F; Vavassori A; Polo A; Rondi E; Cambria R; Orecchia R; Tosi G
    Radiother Oncol; 2006 Apr; 79(1):65-9. PubMed ID: 16564593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical problems associated with dosimetry of 125-iodine for cancer of the prostate.
    Abadir R; Logan KW
    J Can Assoc Radiol; 1984 Sep; 35(3):250-3. PubMed ID: 6501379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation dose to the surgeon during plaque brachytherapy.
    Classic KL; Furutani KM; Stafford SL; Pulido JS
    Retina; 2012 Oct; 32(9):1900-5. PubMed ID: 22487580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapy.
    Frank SJ; Tailor RC; Kudchadker RJ; Martirosyan KS; Stafford RJ; Elliott AM; Swanson DA; Sing D; Choi J; Mourtada F; Ibbott GS
    Med Dosim; 2011; 36(2):200-5. PubMed ID: 20537886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation exposure to operating room personnel during transperineal interstitial permanent prostate brachytherapy.
    Schwartz DJ; Davis BJ; Vetter RJ; Pisansky TM; Herman MG; Wilson TM; LaJoie WN; Oberg AL
    Brachytherapy; 2003; 2(2):98-102. PubMed ID: 15062147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physical and technical quality assurance and radiation protection in transperineal interstitial permanent prostate brachytherapy with 125-iodine seeds].
    Kaulich TW; Lamprecht U; Paulsen F; Lorenz J; Maurer U; Loeser W; Bichler KH; Nüsslin F; Bamberg M
    Strahlenther Onkol; 2002 Dec; 178(12):667-75. PubMed ID: 12491054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of urinary catheterization on dosimetry after prostate implant brachytherapy with palladium-103 or iodine-125.
    Shirvani SM; Kudchadker RJ; Bruno TL; Likhacheva A; Swanson DA; Frank SJ
    Brachytherapy; 2011; 10(4):269-74. PubMed ID: 21296031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of physician eye lens doses during permanent seed implant brachytherapy for prostate cancer.
    Penfold SN; Marcu L; Lawson JM; Asp J
    J Radiol Prot; 2012 Sep; 32(3):339-47. PubMed ID: 22854245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
    Pickett B; Pouliot J
    Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98.
    International Commission on Radiological Protection
    Ann ICRP; 2005; 35(3):iii-vi, 3-50. PubMed ID: 16330284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of high- and low-source strength (125)I prostate seed implants.
    Narayana V; Troyer S; Evans V; Winfield RJ; Roberson PL; McLaughlin PW
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):44-51. PubMed ID: 15629592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple expression for estimating doses recorded by personnel dosimeters as a result of radioiodine therapy.
    Homann SG
    Health Phys; 1977 Oct; 33(4):337-9. PubMed ID: 599035
    [No Abstract]   [Full Text] [Related]  

  • 15. Variations in health-related quality of life in Japanese men who underwent iodine-125 permanent brachytherapy for localized prostate cancer.
    Tanaka N; Fujimoto K; Asakawa I; Hirayama A; Yoneda T; Yoshida K; Hirao Y; Hasegawa M; Konishi N
    Brachytherapy; 2010; 9(4):300-6. PubMed ID: 20708440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of a pretreatment method to predict the number of I-125 seeds required for prostate brachytherapy.
    Al-Qaisieh B; Brearley E; St Clair S; Flynn A
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):304-7. PubMed ID: 16618585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hand exposure of nuclear medicine workers during administration of radioiodine.
    Wrzesien M; Olszewski J
    Radiat Prot Dosimetry; 2012 Aug; 151(1):147-52. PubMed ID: 22147924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose tables for 125I seed implants.
    Krishnaswamy V
    Radiology; 1979 Sep; 132(3):727-30. PubMed ID: 472255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure of treating physician to radiation during prostate brachytherapy using iodine-125 seeds: dose measurements on both hands with thermoluminescence dosimeters.
    Schiefer H; von Toggenburg F; Seelentag W; Plasswilm L; Ries G; Lenggenhager C; Schmid HP; Leippold T; Prikler L; Krusche B; Roth J; Engeler D
    Strahlenther Onkol; 2009 Oct; 185(10):689-95. PubMed ID: 19806335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo dosimetry with a linear MOSFET array to evaluate the urethra dose during permanent implant brachytherapy using iodine-125.
    Bloemen-van Gurp EJ; Haanstra BK; Murrer LH; van Gils FC; Dekker AL; Mijnheer BJ; Lambin P
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1266-72. PubMed ID: 19665317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.